Repatha (evolocumab) is a PCSK9 inhibitor for lowering LDL cholesterol. It currently comes in one form: the SureClick Autoinjector pen. The Pushtronex on-body infusor was discontinued in June 2024 and ...
Repatha’s dosage varies according to the condition it is being used to treat, with options for administration every 2 weeks or monthly. For example, Repatha’s dosage for lowering cholesterol is ...
Richard Mullvain, RPh, BCPS (AQC), CCCC, a cardiovascular clinical pharmacist and expert in cardiovascular care at the Essentia Health Heart & Vascular Center in Duluth, Minnesota, delivered a focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results